130 related articles for article (PubMed ID: 5564508)
1. [Studies of the pH of drugs administered parenterally].
Zietkiewicz W; Kostrzewska E
Pol Tyg Lek; 1971 Jun; 26(25):937-9. PubMed ID: 5564508
[No Abstract] [Full Text] [Related]
2. Administering parenteral drugs.
Geolot DH; McKinney NP
Am J Nurs; 1975 May; 75(5):788-93. PubMed ID: 1039265
[No Abstract] [Full Text] [Related]
3. [Administration of drugs in infusions].
Honig C
Ned Tijdschr Geneeskd; 1972 Jan; 116(5):189-94. PubMed ID: 5028757
[No Abstract] [Full Text] [Related]
4. [Physicochemical incompatibilities of injectable drugs].
Hoffman M; Hazebroucq G
Sem Hop; 1983 Feb; 59(8):541-7. PubMed ID: 6302899
[No Abstract] [Full Text] [Related]
5. Guidelines for the administration of commonly used intravenous drugs.
Rapp RP; Wermeling DP; Piecoro JJ
Drug Intell Clin Pharm; 1984 Mar; 18(3):217-32. PubMed ID: 6697884
[No Abstract] [Full Text] [Related]
6. Bioavailability of parenteral drugs II. Parenteral doses other than intravenous and intramuscular routes.
Tse FL; Welling PG
J Parenter Drug Assoc; 1980; 34(6):484-95. PubMed ID: 6906371
[No Abstract] [Full Text] [Related]
7. [Drug interaction].
Wójcicki J
Pol Tyg Lek; 1971 May; 26(22):838-41. PubMed ID: 4933183
[No Abstract] [Full Text] [Related]
8. A cost-effective guide for the prevention of chemical phlebitis caused by the pH of the pharmaceutical agent.
Harrigan CA
NITA; 1984; 7(6):478-82. PubMed ID: 6568460
[No Abstract] [Full Text] [Related]
9. [Incompatibility and other problems in adding drugs to intravenous fluids].
Hvidberg E; Bols T; Jacobsen N
Ugeskr Laeger; 1973 Jun; 135(24):1221-9. PubMed ID: 4754570
[No Abstract] [Full Text] [Related]
10. The pH and osmolality of intravenously used drugs.
Mostert JW
JAMA; 1971 May; 216(9):1483. PubMed ID: 5108527
[No Abstract] [Full Text] [Related]
11. [Local adverse reactions associated with parenteral administration of drugs].
Bjånes TK
Tidsskr Nor Laegeforen; 2011 Mar; 131(5):472-4. PubMed ID: 21383802
[TBL] [Abstract][Full Text] [Related]
12. pH vs acid load.
Harrow BR
N Engl J Med; 1969 Jun; 280(26):1481. PubMed ID: 5786528
[No Abstract] [Full Text] [Related]
13. Periodicity during the distributive phase for drugs administered intravenously to humans.
Wood JH; Lee AJ; Garrettson LK
Drug Metab Rev; 1979; 9(1):119-28. PubMed ID: 446264
[No Abstract] [Full Text] [Related]
14. [Unreliable absorption after intramuscular injection of certain drugs].
Lunde PK
Tidsskr Nor Laegeforen; 1975 Jul; 95(19-21):1174. PubMed ID: 1166432
[No Abstract] [Full Text] [Related]
15. Bioavailability of parenteral drugs I. Intravenous and intramuscular doses.
Tse FL; Welling PG
J Parenter Drug Assoc; 1980; 34(5):409-21. PubMed ID: 6905871
[No Abstract] [Full Text] [Related]
16. [Study on the pH of Hartmann solution, with special reference to several cases].
Fujita T; Fukushima K; Fujiwara T; Ishikawa ; Hanai Y
Masui; 1967 Dec; 16(13):1161-7. PubMed ID: 5628277
[No Abstract] [Full Text] [Related]
17. Solid lipid nanoparticles for parenteral drug delivery.
Wissing SA; Kayser O; Müller RH
Adv Drug Deliv Rev; 2004 May; 56(9):1257-72. PubMed ID: 15109768
[TBL] [Abstract][Full Text] [Related]
18. Dosage calculations for drugs administered by infusion.
Zenk KE
Am J Hosp Pharm; 1980 Oct; 37(10):1304-5. PubMed ID: 7424921
[No Abstract] [Full Text] [Related]
19. Interactions between drugs and intravenous delivery systems.
Kowaluk EA; Roberts MS; Polack AE
Am J Hosp Pharm; 1982 Mar; 39(3):460-7. PubMed ID: 7072732
[TBL] [Abstract][Full Text] [Related]
20. [A dilution method for drugs administered by continuous infusion].
Cléro B; Atinault A; Louville Y; Barrier G
Agressologie; 1988 Nov; 29(11 Spec No):767-8. PubMed ID: 3247901
[No Abstract] [Full Text] [Related]
[Next] [New Search]
